cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Nanang Yunarto
Contact Email
jurnalkefarmasian@gmail.com
Phone
+628156867400
Journal Mail Official
jurnalkefarmasian@gmail.com
Editorial Address
Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan Kementerian Kesehatan RI Jl. Percetakan Negara No. 23 - Jakarta 10560
Location
Kota adm. jakarta pusat,
Dki jakarta
INDONESIA
Jurnal Kefarmasian Indonesia
Published by Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan
ISSN : 2085675X     EISSN : 23548770     DOI : -
Core Subject : Health, Science,
Chemistry Medicine & Pharmacology
Pharmaceutical Technology, Pharmacology, Pharmaceutical Chemistry, Traditional Medicines, and Pharmaceutical Care.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Pharmacology, Toxicology and Pharmaceutics (Lain-Lain)
Articles 269 Documents
 12   13   14   15   16 
Uji Bioavailabilitas Tablet Floating Aspirin Siswanto, Agus; Fudholi, Achmad; Nugroho, Akhmad Kharis; Martono, Sudibyo
Jurnal Kefarmasian Indonesia VOLUME 7, NOMOR 2, AGUSTUS 2017
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v7i2.3498

Abstract

Aspirin is a non-steroidal anti-inflammatory drug with potential as antiplatelet for stroke prophylaxis. Several approaches of aspirin formulations in various dosage forms have been performed. Formulations of aspirin in conventional tablet dosage form often cause gastric irritation. Aspirin is rapidly absorbed in the upper gastrointestinal tract, especially the first small intestine. Therefore formulation of floating drug delivery system are designed to improve the bioavailability of aspirin. The floating system will retain the tablet in stomach, allowing sufficient absorption time for aspirin in stomach and upper intestine. Aim of this study was to determine relative bioavailability of aspirin floating tablets compared to the aspirin enteric coated tablets in rabbits with crossover design method. Serial blood samples were collected from rabbit ear marginal vein over a 10-h period. Drugs concentration in plasma (aspirin and salisylic acid) were determined by HPLC with benzoic acid as internal standard. The results showed that the floating aspirin tablet has better bioavailability with shorter tmax and more uniform of aspirin levels compared to enteric coated tablets, though the parameters AUC and Cpmax both of those products were not significant (p> 0.05).
Gambaran Drug Related Problems (DRPs) pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Tuminting Tampa'i, Randy; Sumombo, Jacklyne; Hariyadi, Hariyadi; Lengkey, Yessie
Jurnal Kefarmasian Indonesia VOLUME 11, NOMOR 1, FEBRUARI 2021
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v11i1.3499

Abstract

Diabetes mellitus (DM) is a chronic disease with a very high complication rate and the third-highest cause of death in Indonesia. The management of DM cannot be separated from the action of drug therapy. It is necessary to have pharmaceutical care in handling drug related problems (DRPs) in order to achieve optimal drug effects on patients. The purpose of this study is to describe the characteristics and incidence of DRPs in type 2 DM patients at the Tuminting Public Health Centre, Manado. Sampling of 42 samples is conducted with a purposive sampling method using medical records and patient medical treatment history data for type 2 DM patients retrospectively from January to June 2019. The data is analyzed descriptively. The results obtained from the incidence of type 2 diabetes mellitus in women were 53.10% and men 46.90%. Most patients with type 2 diabetes were at the age of >60 years, 66.67%. The highest co-morbidity were cardiovascular disorders 24,24%. The most widely used antihyperglycemic drug was metformin 72.50%. The most DRPs incidence occurred in May 2019 at 36.36%, with 59.05% was needing drugs was, 13.64% did not need drugs, 20.45% wrong drugs, 2.27% less dose and 4.55% over dose.
Formulasi dan Uji Stabilitas Fisik Sediaan Gel Ekstrak Daun Ketepeng Cina (Cassia alata L.) Sayuti, Nutrisia Aquariushinta
Jurnal Kefarmasian Indonesia VOLUME 5, NOMOR 2, AGUSTUS 2015
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v5i2.3500

Abstract

Cassia alata L. leaf contains flavonoids which have anti-inflammatory, anti-allergy, antioxidants and antifungal effects. The traditional application of it requires long preparation time so we need a formulation with more practical and durable storage is needed. Gel formulation was chosen because it is easy to dry, forming an easy to wash film layer and give a sense of cold on the skin. Gel components affect the stability of the gel. Physical stability is analyzed to ensure that the formulated gel’s quality, safety and benefits meet the specifications and survive during storage. This study aimed to create a gel formula and analysed its physical stability test of Cassia alata L. leaf extract gel. Research design adopted in this study was an experimental laboratory. Optimum gel formula determined by variations in the concentration of sodium carboxymethyl celulose (CMCNa). Gel that meet the criteria of homogeneity, consistency, pH and spreadibility was set as the optimum formula. Physical stability of optimum formula was analyzed by organoleptic, homogeneity test, pH test, viscosity test and spredability test. Gel that meets the acceptance criteria are Cassia alata L. leaf extract gel with CMC-Na concentration of 3% those determined as the optimum formula. Stability analysis of optimum formula didn’t show any changes in pH, color, smell and taste, although it changes of the shape, viscosity and spreadibility were found. The optimum formula gel obtained by the concentration of CMC-Na 3%. results were less stable during the 8 weeks of storage at a temperature of 40°C.
Evaluasi Penggunaan Antibiotik pada Pasien Rawat Inap di Bangsal Penyakit Dalam RSUD. Dr. H. Abdul Moeloek Provinsi Lampung Dirga, Dirga; Khairunnisa, Sudewi Mukaromah; Akhmad, Atika Dalili; Setyawan, Irfanianta Arif; Pratama, Anton
Jurnal Kefarmasian Indonesia VOLUME 11, NOMOR 1, FEBRUARI 2021
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v11i1.3570

Abstract

The high prevalence of infectious disease in Indonesia causes increased use of antibiotics. It has serious consequences since it can cause germicidal resistance rapidly increased, significant morbidity and mortality, as well as high additional medical costs per year. This study aims to evaluate the appropriateness of antibiotic use inpatients in the internal medicine ward of Dr. H. Abdul Moeloek in Lampung Province. This research was observational (non-experimental) with a descriptive evaluative research design. The data were obtained from the retrospective tracing of medical records that collected by a purposive sampling technique on July-December 2017. A total of 163 inclusion samples are analyzed qualitatively and quantitatively. The qualitative analysis uses standard guidelines for the use of antibiotics and quantitative analysis uses the anatomical therapeutic chemical (ATC)/Defined Daily Dose (DDD) method. The results showed that out of 168 medical records, 19 types of antibiotics were used with a 118.57 DDD value of 100 patient days. The most widely prescribed was ceftriaxone (49.09%). The highest number of infections was diabetic ulcers with an incidence of 42 cases (25%). Out of 168 evaluated cases, 166 cases (98.8%) were appropriate indication, 168 cases (100%) were appropriate patients, 150 cases (89,29%) were appropriate medication, and 89 cases (52,97%) were appropriate dosage. These results indicated that the use of antibiotics inpatients in the internal medicine ward of Dr. H. Abdul Moeloek in Lampung Province were rational but it was necessary to consider selectivity regarding the choice of antibiotic use for infected patients.
Kepatuhan Minum Obat pada Pasien Diabetes Melitus Tipe 2 di Beberapa Puskesmas Kabupaten Banyumas Aji Wibowo, Much Ilham Novalisa; Fitri, Febiana Melisa; Yasin, Nanang Munif; Kristina, Susi Ari; Prabandari, Yayi Suryo
Jurnal Kefarmasian Indonesia VOLUME 11, NOMOR 2, AGUSTUS 2021
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v11i2.3635

Abstract

Diabetes mellitus (DM) is considered as ”the mother of all diseases" because it causes many complications. Knowing and measuring medication adherence may have a greater effect on DM patients. Several studies in Indonesia used a questionnaire scale to measure adherence, however they do not validate the study population, so it could still be found anomalous correlation analysis between adherence and clinical data even though it measured in the same country and scale. This study measure the adherence level of type 2 diabetes patients, evaluates the validity of the medication adherence scale, and analyze the correlation with the clinical outcome of type 2 diabetes patients in four health centers in Banyumas district. The study uses a cross-sectional design in Prolanis type 2 DM patients of January -April 2020. The adherence is measured by MARS-10, backward-forward translation method followed by content and internal validation. Clinical outcome is evaluated based on fasting blood glucose measurement. The results of the MARS-10 Gregory index analysis showed content validity in the high category (IG ≥ 0.8). The content validity showed the results of 9 questions with the value of r count> r table (n = 30, r table = 0.361). Reliability analysis showed Cronbach's Alpha 0.747> 0.6. The measurement showed 80.3% was adherent patients and 19.3% was non-adherent patients. Correlation analysis showed that there was no significant relationship (p> 0.05) between patient adherence and clinical outcome. Those results showed that type 2 diabetes mellitus patients in 4 health centers were categorized as adherent but not correlated with the clinical outcome. This was enable due to the clinical outcome was simultaneously influenced by several factors: general factors, individual factors, and unpredictable factors.
Front Matter Volume 8 No 1 Tahun 2018 Kurniatri, Arifayu Addiena
Jurnal Kefarmasian Indonesia VOLUME 8, NOMOR 1, FEBRUARI 2018
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Back Matter Volume 8 No 1 Tahun 2018 Kurniatri, Arifayu Addiena
Jurnal Kefarmasian Indonesia VOLUME 8, NOMOR 1, FEBRUARI 2018
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Konsentrasi Aman Kurkumin dan PGV-0 terhadap Sel Vero Berdasarkan Hasil Uji Sitotoksik Marbawati, Dewi; Sarjiman, Sarjiman
Jurnal Kefarmasian Indonesia VOLUME 5, NOMOR 2, AGUSTUS 2015
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v5i2.3687

Abstract

Curcumin (1,7-bis(3-methoxyphenyl 4'hidroksi) -1.6 heptadien, 3,5-dione) is the yellow pigment of Curcuma longa. Curcumin has various biological activities such as antioxidant, antibacterial, antifungal, antiprotozoal and antivirus. Various benefits of curcumin can not be separated from the weakness which is not stable to pH and light. Pentagamavunon-0 (PGV-0) were made by changing the β diketone group on cluster analog of curcumin into monoketon while eliminating active methylene group so it is more stable to pH and light. PGV-0 also has potential as a stronger antioxidant and antiinflammatory agent than other curcumin analogues. The objective of this research was to determine the safe concentrations of curcumin and PGV-0 on vero cells due to the increased use of the two compounds through the cytotoxic test. This research includes experimental research. Cytotoxic test performed with microculture tetrazolium technique (MTT) method. Use of MTT to evaluate the cytotoxic is based on changes of tetrazolium salt into formazan crystals by mitochondrial enzyme succinate dehydrogenase with the help of cellular NADH. The results showed that the safe concentrations of curcumin and PGV-0 on vero cells respectively are 6.25 and 1.5625 ppm. Based on the cytotoxic test the secure concentration of curcumin was higher than PGV-0.
Formulasi Tablet Salut Selaput Katekin dari Ekstrak Gambir (Uncaria gambir Roxb.) Kurniatri, Arifayu Addiena; Adelina, Rosa; Setyorini, Herni Asih; Sulistyowati, Indah
Jurnal Kefarmasian Indonesia VOLUME 5, NOMOR 2, AGUSTUS 2015
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v5i2.3688

Abstract

Gambir extract contains a high content of catechin. Catechin has so many benefits, such as antioxidant, antimicrobial, and anti-atherosclerosis.Gambir are widely available in Indonesia, especially in West Sumatra, might be a sustainable source of catechin. Catechin is easily oxidized and hygroscopic. Film coating is used to protect catechin contained in a tablet from moisture and light. Study of film-coated tablet of catechin has not been conducted before. This study aims to formulate film-coated tablet of catechin from gambir and evaluate its physical properties. Catechin was percolated from gambir extract using ethyl astetat. The ethyl acetate fraction of gambir extract contains 92,48±0,28% catechin. Tablets were compressed with direct compression method and coated with a polymer coating material. The physical properties of core tablet and film-coated tablet were evaluated toward weight uniformity, hardness, friability, and disintegration time. Friability testing was conducted only on core tablet. The formulation produced tablets with uniform weight, 16,6 ±1,97 Kp hardness, and 4 minutes 15 seconds disintegration time. Weight uniformity and disintegration time of the tablet meet the requirements.
Profil Disolusi Terbanding, Penetapan Kadar, dan Kualitas Fisik Tablet Atorvastatin Inovator, Generik Bernama Dagang, dan Generik Aini, Nurul; Saraswati, Ratih Dian; Oktoberia, Intan Sari
Jurnal Kefarmasian Indonesia VOLUME 5, NOMOR 2, AGUSTUS 2015
Publisher : Pusat Penelitian dan Pengembangan Biomedis dan Teknologi Dasar Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22435/jki.v5i2.3689

Abstract

Atorvastatin is one of the statins which is used as the first line therapy for hyperlipidemia. The patent of atorvastatin innovator ended in 2011. Besides the innovator brand of atorvastatin, several brand and one generic atorvastatin tablet are currently marketed in Indonesia. In this research, dissolution profiles, assay and physical quality were investigated for three atorvastatin tablet samples consist of one innovator sample, two atorvastatin copy layer products (branded generic atorvastatin sample and atorvastatin generic sample). The dissolution testing were done using FDA (Food and Drug Administration) method. The result shows that the innovator and branded generic samples meet all the requirements for physical quality, meanwhile the generic sample failed to meet the disintegration test criteria. The branded generic sample has similar dissolution profile with the innovator, while the generic tablet was not similar. The assay were conducted using High Performance Liquid Chromatography (HPLC) method. The assay result of the innovator, branded generic, and generic samples respectively were 97,54%, 106,36% and 97,65% which means that all samples comply with general requirement of active pharmaceutical ingredient in tablet.

Page 14 of 27 | Total Record : 269

 12   13   14   15   16 

Filter by Year

2009 2025


Reset
Filter By Issues
All Issue VOLUME 15, NUMBER 2, JULY-DECEMBER 2025 VOLUME 15, NUMBER 1, FEBRUARY 2025 VOLUME 14, NUMBER 2, AUGUST 2024 VOLUME 14, NUMBER 1, FEBRUARY 2024 VOLUME 13, NUMBER 2, AUGUST 2023 VOLUME 13, NOMOR 1, FEBRUARI 2023 VOLUME 12, NOMOR 2, AGUSTUS 2022 VOLUME 12, NOMOR 1, FEBRUARI 2022 VOLUME 11, NOMOR 2, AGUSTUS 2021 VOLUME 11, NOMOR 1, FEBRUARI 2021 VOLUME 10, NOMOR 2, AGUSTUS 2020 VOLUME 10, NOMOR 1, FEBRUARI 2020 VOLUME 9, NOMOR 2, AGUSTUS 2019 VOLUME 9, NOMOR 1, FEBRUARI 2019 VOLUME 8, NOMOR 2, AGUSTUS 2018 VOLUME 8, NOMOR 1, FEBRUARI 2018 VOLUME 7, NOMOR 2, AGUSTUS 2017 VOLUME 7, NOMOR 1, FEBRUARI 2017 VOLUME 6, NOMOR 2, AGUSTUS 2016 VOLUME 6, NOMOR 1, FEBRUARI 2016 VOLUME 5, NOMOR 2, AGUSTUS 2015 VOLUME 5, NOMOR 1, FEBRUARI 2015 VOLUME 4, NOMOR 2, AGUSTUS 2014 VOLUME 4. NOMOR 1 FEBRUARI 2014 VOLUME 3, NOMOR 2, AGUSTUS 2013 VOLUME 3, NOMOR 1, FEBRUARI 2013 VOLUME 2 NOMOR 2, AGUSTUS 2012 VOLUME 2, NOMOR 1, FEBRUARI 2012 VOLUME 1, NOMOR 3, 2009 VOLUME 1, NOMOR 2, 2009 VOLUME 1, NOMOR 1, 2009 More Issue